Safety and Efficacy Study of YZJ-1139 in Primary Chronic Insomnia Disorder

PHASE2CompletedINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

August 4, 2019

Primary Completion Date

September 30, 2020

Study Completion Date

March 29, 2021

Conditions
Insomnia Disorder
Interventions
DRUG

YZJ-1139 10mg

YZJ-1139 10mg tablets

DRUG

YZJ-1139 20mg

YZJ-1139 20mg tablets

DRUG

YZJ-1139 40mg

YZJ-1139 40mg tablets

DRUG

YZJ-1139 60mg

YZJ-1139 60mg tablets

DRUG

Placebo

Match placebo tablets

Trial Locations (33)

Unknown

Beijing HuiLongGuan Hospital, Beijing

Peking University People's Hospital, Beijing

Xuanwu Hospital, Capital Medical University, Beijing

The First Affiliated Hospital of Bengbu Medical College, Bengbu

The First Hospital of Jilin University, Changchun

Hunan Brain Hospital, Changsha

Xiangya Hospital, Central South University, Changsha

West China Hospital, Sichuan University, Chengdu

Army Specialty Medical Center, Chongqing

Guangdong Provincial People's Hospital, Guangzhou

Nanfang Hospital of Southern Medical University (Department of Psychiatry), Guangzhou

Nanfang Hospital, Southern Medical University (Sleep Medicine Center), Guangzhou

The First Affiliated Hospital of Jinan University, Guangzhou

The Second Affiliated Hospital of Anhui Medical University, Hefei

The Affiliated Hospital of Jiujiang University, Jiujiang

The First Affiliated Hospital of Kunming Medical University, Kunming

The First People's Hospital of Yunnan Province, Kunming

Jiangxi Provincial Psychiatric Hospital, Nanchang

Nanjing Drum Tower Hospital, the Affiliated Hospital of Nanjing, Nanjing

The First People 's Hospital of Nantong, Nantong

Qingdao Municipal Hospital, Qingdao

The Second Affiliated Hospital of Fujian Medical University, Quanzhou

Huashan Hospital Affiliated to Fudan University, Shanghai

Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai

The First Hospital of Hebei Medical University, Shijiazhuang

The Third Hospital of Hebei Medical University, Shijiazhuang

The Second Affiliated Hospital of Soochow University, Suzhou

Tianjin Anding Hospital, Tianjin

Wuhan Mental Health Center, Wuhan

Tangdu Hospital, Fourth Military Medical University, PLA, Xi'an

The Second Affiliated Hospital of Xinxiang Medical University, Xinxiang

Henan Provincial People's Hospital, Zhengzhou

The Affiliated Hospital of Zunyi Medical College, Zunyi

All Listed Sponsors
lead

Shanghai Haiyan Pharmaceutical Technology Co., Ltd.

INDUSTRY

NCT06680505 - Safety and Efficacy Study of YZJ-1139 in Primary Chronic Insomnia Disorder | Biotech Hunter | Biotech Hunter